Hereditary nonpolyposis colorectal cancer medical therapy: Difference between revisions
No edit summary |
|||
Line 5: | Line 5: | ||
==Overview== | ==Overview== | ||
There is no medical treatment for hereditary nonpolyposis colorectal cancer.<ref name="pmid26474631">{{cite journal |vauthors=Si JW, Wang L, Ba XJ, Zhang X, Dong Y, Zhang JX, Li WT, Li T |title=[Clinicopathological screening of Lynch syndrome: a report of 2 cases and literature review] |language=Chinese |journal=Beijing Da Xue Xue Bao |volume=47 |issue=5 |pages=858–64 |year=2015 |pmid=26474631 |doi= |url=}}</ref><ref name="pmid16870997">{{cite journal |vauthors=Hendriks YM, de Jong AE, Morreau H, Tops CM, Vasen HF, Wijnen JT, Breuning MH, Bröcker-Vriends AH |title=Diagnostic approach and management of Lynch syndrome (hereditary nonpolyposis colorectal carcinoma): a guide for clinicians |journal=CA Cancer J Clin |volume=56 |issue=4 |pages=213–25 |year=2006 |pmid=16870997 |doi= |url=}}</ref> However, | There is no medical treatment for hereditary nonpolyposis colorectal cancer.<ref name="pmid26474631">{{cite journal |vauthors=Si JW, Wang L, Ba XJ, Zhang X, Dong Y, Zhang JX, Li WT, Li T |title=[Clinicopathological screening of Lynch syndrome: a report of 2 cases and literature review] |language=Chinese |journal=Beijing Da Xue Xue Bao |volume=47 |issue=5 |pages=858–64 |year=2015 |pmid=26474631 |doi= |url=}}</ref><ref name="pmid16870997">{{cite journal |vauthors=Hendriks YM, de Jong AE, Morreau H, Tops CM, Vasen HF, Wijnen JT, Breuning MH, Bröcker-Vriends AH |title=Diagnostic approach and management of Lynch syndrome (hereditary nonpolyposis colorectal carcinoma): a guide for clinicians |journal=CA Cancer J Clin |volume=56 |issue=4 |pages=213–25 |year=2006 |pmid=16870997 |doi= |url=}}</ref> However, hereditary nonpolyposis colorectal cancer patients should consider diet optimization and pharmacological prevention. | ||
==Medical Therapy== | ==Medical Therapy== | ||
Line 15: | Line 15: | ||
===Pharmacological Prevention=== | ===Pharmacological Prevention=== | ||
*Drugs lowering the risk of colorectal cancer include: aspirin, sulindac, prioxicam, calcium, and vitamin C. The real value of such drugs in cancer prevention in | *Drugs lowering the risk of colorectal cancer include: aspirin, sulindac, prioxicam, calcium, and vitamin C. The real value of such drugs in cancer prevention in hereditary nonpolyposis colorectal cancer cannot be excluded, but is not proven.<ref name="pmid26474631">{{cite journal |vauthors=Si JW, Wang L, Ba XJ, Zhang X, Dong Y, Zhang JX, Li WT, Li T |title=[Clinicopathological screening of Lynch syndrome: a report of 2 cases and literature review] |language=Chinese |journal=Beijing Da Xue Xue Bao |volume=47 |issue=5 |pages=858–64 |year=2015 |pmid=26474631 |doi= |url=}}</ref> | ||
==References== | ==References== | ||
Line 22: | Line 22: | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Types of cancer]] | [[Category:Types of cancer]] | ||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} |
Revision as of 15:11, 9 February 2016
Hereditary Nonpolyposis Colorectal Cancer Microchapters |
Differentiating Hereditary Nonpolyposis Colorectal Cancer from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
Hereditary nonpolyposis colorectal cancer medical therapy On the Web |
American Roentgen Ray Society Images of Hereditary nonpolyposis colorectal cancer medical therapy |
FDA on Hereditary nonpolyposis colorectal cancer medical therapy |
CDC on Hereditary nonpolyposis colorectal cancer medical therapy |
Hereditary nonpolyposis colorectal cancer medical therapy in the news |
Blogs on Hereditary nonpolyposis colorectal cancer medical therapy |
Directions to Hospitals Treating Hereditary nonpolyposis colorectal cancer |
Risk calculators and risk factors for Hereditary nonpolyposis colorectal cancer medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Maria Fernanda Villarreal, M.D. [2]
Overview
There is no medical treatment for hereditary nonpolyposis colorectal cancer.[1][2] However, hereditary nonpolyposis colorectal cancer patients should consider diet optimization and pharmacological prevention.
Medical Therapy
HNPCC patients should consider the following options of medical management:[3]
Diet Optimization
- Persons with high risk of colorectal cancer should consider a low fat diet with limitations concerning red meat. Conversely, dietary approaches should consider the inclusion of high fiber and rich in cellulose foods.
Pharmacological Prevention
- Drugs lowering the risk of colorectal cancer include: aspirin, sulindac, prioxicam, calcium, and vitamin C. The real value of such drugs in cancer prevention in hereditary nonpolyposis colorectal cancer cannot be excluded, but is not proven.[1]
References
- ↑ 1.0 1.1 Si JW, Wang L, Ba XJ, Zhang X, Dong Y, Zhang JX, Li WT, Li T (2015). "[Clinicopathological screening of Lynch syndrome: a report of 2 cases and literature review]". Beijing Da Xue Xue Bao (in Chinese). 47 (5): 858–64. PMID 26474631.
- ↑ Hendriks YM, de Jong AE, Morreau H, Tops CM, Vasen HF, Wijnen JT, Breuning MH, Bröcker-Vriends AH (2006). "Diagnostic approach and management of Lynch syndrome (hereditary nonpolyposis colorectal carcinoma): a guide for clinicians". CA Cancer J Clin. 56 (4): 213–25. PMID 16870997.
- ↑ Kladny J, Lubinski J. Lynch syndrome (HNPCC). Hered Cancer Clin Pract. 2008;6(2):99-102.